WuXi PharmaTech’s Venture Unit Closes $290M Second Fund

This Data Is Locked!

This area is available only to Subscribers.

WuXi Healthcare Ventures, the venture capital arm of New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech, has closed its second venture... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?